🟢 NMRA is trading 5% up today as it extends its rebound from a Phase 3 trial failure selloff

NMRA is trading 5% up today at $1.73 as the stock continues to rebound from a recent selloff triggered by a Phase 3 depression trial failure.

• Today's price action appears to be driven by technical bargain hunting and market repricing rather than new fundamental developments.
• Broader market strength and improved risk appetite are providing additional support for the stock's recovery.